Dual anti-HIV gene transfer construct

· Calimmune, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dual anti-HIV gene transfer construct, covering 2020-08-06 to 2020-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection [Phase 1, Phase 2]